利用p53改善肺癌治疗的免疫疗法
1Department of Pathology, Stony Brook University, Stony Brook, New York.
Cancer research
|December 21, 2023
概括
p53突变和瘤异质性可能导致肺癌对免疫检查点阻塞 (ICB) 治疗产生抵抗力,即使瘤突变负担 (TMB) 高. 将ICB与STING激动剂或p53诱导剂结合使用可能会提高治疗疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 免疫检查点封锁 (ICB) 是一个关键的肺癌治疗方法.
- 瘤突变负担 (TMB) 预测了ICB反应.
- 肺癌中ICB抗性的机制需要进一步阐明.
研究的目的:
- 研究p53突变和瘤异质性在肺癌对ICB抗性的作用.
- 探索新的治疗策略,以提高ICB在肺癌中的疗效.
主要方法:
- 利用本土和同源的肺癌小鼠模型.
- 分析了p53损失和瘤异质性对免疫反应和ICB疗效的影响.
- 评估TMB,共享突变和cGAS/STING信号通路.
主要成果:
- 在KrasG12D小鼠中失去p53导致免疫抑制瘤微环境,减少ICB反应.
- 高的TMB,虽然通常是免疫性,但可以与由于瘤异质性和免疫逃逸的抵抗有关.
- 降低cGAS/STING信号可能导致ICB电阻.
结论:
- p53突变和瘤异质性是推动肺癌中ICB耐药性的关键因素.
- 涉及ICB与STING激动剂或p53诱导剂的联合疗法显示出克服抗性的前景.
- 这项研究为了解和治疗ICB耐药肺癌提供了一个新的模型.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K


